Craneware (CRW) Competitors

65.9% of Instem shares are owned by institutional investors. Comparatively, 35.7% of Craneware shares are owned by institutional investors. 30.0% of Instem shares are owned by company insiders. Comparatively, 10.3% of Craneware shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Craneware has a consensus target price of GBX 2,222.75, suggesting a potential upside of 74.00%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than Instem.

In the previous week, Instem's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Craneware has a net margin of 10.63% compared to Instem's net margin of 5.50%. Craneware's return on equity of 6.65% beat Instem's return on equity.

Instem has a beta of 0.42, meaning that its stock price is 58% less volatile than the broader market. Comparatively, Craneware has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market.

Craneware has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Craneware has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market. Comparatively, Kooth has a beta of 1.286, meaning that its stock price is 29% more volatile than the broader market.

Craneware currently has a consensus target price of GBX 2,222.75, suggesting a potential upside of 74.00%. Kooth has a consensus target price of GBX 330, suggesting a potential upside of 127.59%. Given Kooth's higher possible upside, analysts plainly believe Kooth is more favorable than Craneware.

35.7% of Craneware shares are held by institutional investors. Comparatively, 20.9% of Kooth shares are held by institutional investors. 10.3% of Craneware shares are held by insiders. Comparatively, 30.4% of Kooth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Craneware has higher revenue and earnings than Kooth. Craneware is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

In the previous week, Kooth had 1 more articles in the media than Craneware. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Craneware. Kooth's average media sentiment score of 1.32 beat Craneware's score of 0.00 indicating that Kooth is being referred to more favorably in the news media.

Craneware has a net margin of 10.63% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Craneware's return on equity.

Renalytix has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

Craneware has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

In the previous week, Renalytix's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Craneware has a net margin of 10.63% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Craneware's return on equity.

14.0% of Renalytix shares are owned by institutional investors. Comparatively, 35.7% of Craneware shares are owned by institutional investors. 5.1% of Renalytix shares are owned by insiders. Comparatively, 10.3% of Craneware shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Craneware has a consensus target price of GBX 2,222.75, suggesting a potential upside of 74.00%. Given Craneware's stronger consensus rating and higher possible upside, analysts plainly believe Craneware is more favorable than Renalytix.

Craneware presently has a consensus price target of GBX 2,222.75, indicating a potential upside of 74.00%. Cambridge Cognition has a consensus price target of GBX 56, indicating a potential upside of 64.71%. Given Craneware's higher probable upside, equities research analysts plainly believe Craneware is more favorable than Cambridge Cognition.

Craneware has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.809, indicating that its stock price is 19% less volatile than the broader market.

In the previous week, Cambridge Cognition had 1 more articles in the media than Craneware. MarketBeat recorded 1 mentions for Cambridge Cognition and 0 mentions for Craneware. Cambridge Cognition's average media sentiment score of 0.43 beat Craneware's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Craneware has a net margin of 10.63% compared to Cambridge Cognition's net margin of -17.82%. Craneware's return on equity of 6.65% beat Cambridge Cognition's return on equity.

35.7% of Craneware shares are owned by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are owned by institutional investors. 10.3% of Craneware shares are owned by insiders. Comparatively, 3.2% of Cambridge Cognition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Craneware has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.